The table below shows TransMedics Group, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$605.49M
$441.54M
$241.62M
$93.46M
$30.26M
$25.64M
Cost of revenue
$242.69M
$179.46M
$87.53M
$28.19M
$9.10M
$9.00M
Gross profit
$362.81M
$262.08M
$154.09M
$65.27M
$21.16M
$16.64M
R&D
$69.06M
$55.97M
$36.05M
$26.81M
$22.30M
$18.83M
TMDX annual revenue (10-K history)
TransMedics Group, Inc. reported annual revenue of $605.49M for fiscal year 2025. That is up 37.1% from $441.54M in fiscal 2024. Over the 8 fiscal years shown, annual revenue grew from $13.02M (FY 2018) to $605.49M. Figures come from the company's audited annual reports as filed with the SEC.